Low Intensity, Transcranial, Alternating Current Stimulation Reduces Migraine Attack Burden in a Home Application Set-Up: A Double-Blinded, Randomized Feasibility Study
- PMID: 33233400
- PMCID: PMC7700448
- DOI: 10.3390/brainsci10110888
Low Intensity, Transcranial, Alternating Current Stimulation Reduces Migraine Attack Burden in a Home Application Set-Up: A Double-Blinded, Randomized Feasibility Study
Abstract
Background: Low intensity, high-frequency transcranial alternating current stimulation (tACS) applied over the motor cortex decreases the amplitude of motor evoked potentials. This double-blind, placebo-controlled parallel group study aimed to test the efficacy of this method for acute management of migraines. Methods: The patients received either active (0.4 mA, 140 Hz) or sham stimulation for 15 min over the visual cortex with the number of terminated attacks two hours post-stimulation as the primary endpoint, as a home therapy option. They were advised to treat a maximum of five migraine attacks over the course of six weeks. Results: From forty patients, twenty-five completed the study, sixteen in the active and nine in the sham group with a total of 102 treated migraine attacks. The percentage of terminated migraine attacks not requiring acute rescue medication was significantly higher in the active (21.5%) than in the sham group (0%), and the perceived pain after active stimulation was significantly less for 2-4 h post-stimulation than after sham stimulation. Conclusion: tACS over the visual cortex has the potential to terminate migraine attacks. Nevertheless, the high drop-out rate due to compliance problems suggests that this method is impeded by its complexity and time-consuming setup.
Keywords: acute treatment; migraine; tACS; transcranial stimulation; visual cortex.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.Lancet Neurol. 2010 Apr;9(4):373-80. doi: 10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4. Lancet Neurol. 2010. PMID: 20206581 Clinical Trial.
-
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.J Headache Pain. 2018 Nov 1;19(1):101. doi: 10.1186/s10194-018-0929-0. J Headache Pain. 2018. PMID: 30382909 Free PMC article. Clinical Trial.
-
Prophylactic treatment in menstrual migraine: A proof-of-concept study.J Neurol Sci. 2015 Jul 15;354(1-2):103-9. doi: 10.1016/j.jns.2015.05.009. Epub 2015 May 14. J Neurol Sci. 2015. PMID: 26003225 Clinical Trial.
-
Acupuncture for the prevention of episodic migraine.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD001218. doi: 10.1002/14651858.CD001218.pub3. Cochrane Database Syst Rev. 2016. PMID: 27351677 Free PMC article. Review.
-
Efficacy of Noninvasive Brain Stimulation on Pain Control in Migraine Patients: A Systematic Review and Meta-Analysis.Headache. 2016 Nov;56(10):1565-1596. doi: 10.1111/head.12981. Headache. 2016. PMID: 27869996 Review.
Cited by
-
Effectiveness of transcranial alternating current stimulation for controlling chronic pain: a systematic review.Front Neurol. 2023 Dec 20;14:1323520. doi: 10.3389/fneur.2023.1323520. eCollection 2023. Front Neurol. 2023. PMID: 38192572 Free PMC article. Review.
-
An Educational Program for Remote Training and Supervision of Home-Based Transcranial Electrical Stimulation: Feasibility and Preliminary Effectiveness.Neuromodulation. 2023 Aug 8:S1094-7159(23)00671-2. doi: 10.1016/j.neurom.2023.04.477. Online ahead of print. Neuromodulation. 2023. PMID: 37552152
-
Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations.Int J Mol Sci. 2023 Jun 13;24(12):10093. doi: 10.3390/ijms241210093. Int J Mol Sci. 2023. PMID: 37373244 Free PMC article. Review.
-
[Transcranial alternating current stimulation to modulate oscillations in pain disorders].Schmerz. 2023 Aug;37(4):281-289. doi: 10.1007/s00482-022-00684-4. Epub 2022 Dec 12. Schmerz. 2023. PMID: 36508031 Review. German.
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
References
-
- Lipton R.B., Dodick D.W., Silberstein S.D., Saper J.R., Aurora S.K., Pearlman S.H., Fischell R.E., Ruppel P.L., Goadsby P.J. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: A randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–380. doi: 10.1016/S1474-4422(10)70054-5. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
